Back to homepage

Dermatology

Temozolomide and oral etoposide in children with recurrent malignant brain tumors

Authors: Antonio Ruggiero MD, Anna Ariano MD, Silvia Triarico MD, Michele Antonio Capozza MD, Alberto Romano MD, Palma Maurizi MD, Stefano Mastrangelo MD, Giorgio Attinà MD

The article reviews the results
derived from the combination use of TMZ and oral VP-16 to treat malignant brain tumors

More

Psoriasis, biologic therapy, and the pandemic of the 21st century

Authors: Miguel Nogueira MD, Ron Vender MD, Tiago Torres MD, PhD

This editorial discusses the impact of COVID-19 on patients with psoriasis receiving biologic agents.

More

Conjunctivitis in patients with atopic dermatitis treated with dupilumab

Authors: Sandra Ferreira MD, Tiago Torres MD, PhD

The present paper reviews the data of dupilumab-associated conjunctivitis and risk factors in adults with moderate-to-severe AD and other atopic diseases in dupilumab clinical trials and addresses the characteristics and treatment options available for this clinically highly relevant condition.

More

Inflammatory bowel disease in patients with psoriasis treated with interleukin-17 inhibitors

Authors: Keira A Fieldhouse Bsc, Samantha Ukaibe BSc, Erika L Crowley BSc, MSc, Reena Khanna MD, MSc, FRCPC, Ashley O’Toole MD, MHSc, FRCPC, Melinda J Gooderham MD, MSc, FRCPC

This paper reviews all incident cases and exacerbations of IBD reported in the literature during widescale use of IL-17 inhibitors beyond the clinical trials.

More

Corrigendum: Efficacy and safety of photodynamic therapy with RLP068 for diabetic foot ulcers: a review of the literature and clinical experience

Authors: Felicia Pantò MD, Liboria Adamo BSc, Carla Giordano MD, Carmelo Licciardello MD
More